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We report the first description, confirmed by bacteriologic and molecular
(polymerase chain reaction and pulsed-field gel electrophoresis) analysis,
of an infection in animals caused by Lactococcus lactis subsp. lactis, affect-
ing waterfowl. 
Until recently, members of the genus Lactococcus were
considered opportunistic pathogens (1,2). They are often mis-
identified as enterococci or streptococci (3,4), and the difficul-
ties in correctly identifying them have probably hindered
elucidation of their clinical significance. However, the num-
ber of clinical cases associated with infections by these
microorganisms has increased in the last decade in both
humans and animals (5-7). Lactococcus lactis subsp. lactis,
L. piscium, and L. garvieae are recognized as the species
with clinical significance for human and veterinary medicine
(2,8). In humans, L. garvieae and L. lactis subsp. lactis have
been associated with endocarditis (9,10) and have also been
isolated from clinical samples of blood, skin lesions, and
urine (5,7). In veterinary medicine, L. garvieae and L. pis-
cium are pathogenic for various fish species (8,11,12), and L.
garvieae causes mastitis in ruminants (13,14). However,
infection by L. lactis subsp. lactis in animals has not previ-
ously been reported. We present the first microbiologic and
molecular evidence for infection produced by L. lactis subsp.
lactis in waterfowl. 
The Study
From September to November 1998, a mass die-off was
detected among waterfowl in southwestern Spain, affecting
>3,000 birds (0.6% of the total waterfowl population in the
area). The species most affected were coots (Fulica atra)
(26.9%), shovelers ( Anas clypeata) (25.1%), and mallards
(Anas platyrrhynchos) (13.8%). Overall, 20% of the birds
died. Affected birds showed general weakness, evidenced by
drooping wings and sluggishness; approximately 50% had
respiratory distress. At necropsy, most animals had mild
lung congestion; no other lesions were found at postmortem
examination.
Samples from the lungs, liver, and spleen of five dis-
eased birds (one mallard, S-15; three shovelers, S-16, S-18,
and S-19; and one coot, S-17) were submitted to the Animal
Health Department at the School of Veterinary Medicine of
Madrid for microbiologic analysis. After 48 hours of incuba-
tion at 37ºC, pure cultures of weakly a-hemolytic catalase-
negative cocci were obtained on blood agar plates from sam-
ples of lung (S-15, S-16, and S-17) and liver and spleen (S-15,
S-16, S-17, and S-18). All 11 clinical isolates had an identical
biochemical profile, which was identified as L. lactis subsp.
lactis by the Rapid ID 32 Strep system (bioMérieux España,
S.A., Madrid). 
L. lactis subsp. lactis and L. garvieae are the two species
more frequently found in human and animal infections (2).
Routine clinical microbiologic diagnosis requires accurate
discrimination of the two species, as their similar biochemi-
cal reaction patterns may lead to misidentification (2,4).
Although physiologic tests, differences in antimicrobial sus-
ceptibility, whole-cell protein, and DNA or RNA analysis
(4,7,13) have been proposed to distinguish them, some of
these techniques are not reliable or may be too time-consum-
ing, limiting their use for routine identification. For these
reasons, the clinical isolates were also identified by a poly-
merase chain reaction (PCR) assay, which has been success-
fully used to identify many other pathogens (15,16). 
Specific primers LLF 5'-GCAATTGCATCACTCAAAGA
and LLR 5'-ACAGAGAACTTATAGCTCCC were designed
from diagnostic regions of the  L. lactis subsp.  lactis 16S
rRNA gene sequence (accession number M58837). PCR
amplifications were performed in a 100-µL reaction volume
containing 150 ng each of the two primers, 1 mM each of
deoxynucleoside triphosphate, 1 U of Taq DNA polymerase
(Biotools, Inc., Madrid, Spain), and 25 ng of template DNA in
1x reaction buffer. The amplification was carried out in a
PTC-100 thermal cycler (MJ Research, Inc., Watertown,
MA), under the following conditions: initial denaturation at
94ºC for 2 minutes, followed by 30 cycles of denaturation for
1 minute at 92°C, primer annealing for 1.5 minutes at 50°C,
primer extension for 2 minutes at 72°C, and a final extension
of 5 minutes at 72°C. The following bacterial strains were
used to test the specificity of the PCR assay: L. lactis subsp.
lactis, ATCC 19435 and ATTC 11007;  L. garvieae, NCFB
2155; four clinical isolates of  Lactococcus garvieae (1336,
1458, 1982, and 4294, isolated from lactococcosis in trout); L.
piscium, NCFB 2778;  Streptococcus iniae, ATCC 29187;
Vagococcus fluvialis, NCFB 2497; and Enterococcus faecalis,
CECT 481. All the L. lactis subsp. lactis clinical isolates gen-
erated an expected PCR amplification product of 650 bp. No
amplification was observed with any other Lactococcus spe-
cies tested, indicating the specificity of the PCR assay (Fig-
ure 1). These results confirmed those of the biochemical
identification, as well as the utility of this PCR assay for spe-
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cific, rapid, and accurate identification of this microorgan-
ism. In addition, the fact that no PCR amplification was
observed with clinical isolates when tested with a PCR spe-
cific for L. garvieae (17) corroborates the identification (data
not shown).
Pulsed-field gel electrophoresis (PFGE) with the enzyme
SmaI was used for molecular characterization of the clinical
isolates, as described by Vela et al. (18). This technique has
been successfully applied for strain identification and epide-
miologic investigations of lactococci (19,20). Indistinguish-
able restriction patterns were obtained from all clinical
isolates (Figure 2), which were clearly distinct from the pul-
sotypes of  L. lactis subsp.  lactis ATCC 19435, L. garvieae,
and L. piscium (data not shown). These PFGE results indi-
cate that infection was produced by a single strain of L. lactis
subsp. lactis in all the animals studied. The bacteriologic and
molecular results clearly confirm the isolation of  L. lactis
subsp. lactis in waterfowl, the first confirmation of infection
in animals caused by this microorganism.
As L. lactis subsp. lactis is considered nonpathogenic for
animals (1,2) and no additional histopathologic or toxicologic
studies could be carried out in the diseased animals, we can-
not rule out other possible causes for the mass deaths.
Therefore, although the PFGE results, together with the
recovery of L. lactis subsp. lactis in pure culture from the
clinical samples, may suggest clinical significance, no direct
link between the L. lactis subsp. lactis infection and this epi-
sode can be established. Further studies are necessary to
elucidate the exact pathogenic potential of this microorgan-
ism for waterfowl. 
Wild animals, including waterfowl, are known reservoirs
for various pathogens (21). We can only speculate about the
possibility that waterfowl may be a reservoir for this bacte-
rium. However, wild animal reservoirs for other species of
lactococci have been described (22). 
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